Replies to post #6948 on Arch Therapeutics Inc (ARTH)

[tfris]

Hi Regis, I listened to the conference call and thank you and Dr KSS for sharing your knowledge. Do you think it's possible with FDA 510k approval and partner deal, the share price could be high enough to attract institutional investors without a reverse split, providing they uplist?
In the grand scheme of things I guess it doesn't matter- we're in for exciting times hopefully.
Tim